Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Diabetes Care|November 10, 2012
Right ventricular involvement in diabetic cardiomyopathyRalph L Widya, Rutger W van der Meer, Johannes W A Smit, et al.
The Journal of Clinical Endocrinology and Metabolism|April 24, 2008
Effects of short-term high-fat, high-energy diet on hepatic and myocardial triglyceride content in healthy menRutger W van der Meer, Sebastiaan Hammer, Hildo J Lamb, et al.
Journal of the American College of Cardiology|November 22, 2008
Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitusLuuk J Rijzewijk, Rutger W van der Meer, Johannes W A Smit, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 28, 2009
Kinetic models for analysing myocardial [(11)C]palmitate dataHugo W A M de Jong, Luuk J Rijzewijk, Mark Lubberink, et al.
European Heart Journal|May 22, 2008
The ageing male heart: myocardial triglyceride content as independent predictor of diastolic functionRutger W van der Meer, Luuk J Rijzewijk, Michaela Diamant, et al.
Diabetes|August 25, 2007
Short-term caloric restriction induces accumulation of myocardial triglycerides and decreases left ventricular diastolic function in healthy subjectsRutger W van der Meer, Sebastiaan Hammer, Johannes W A Smit, et al.
Radiology|September 22, 2007
Metabolic imaging of myocardial triglyceride content: reproducibility of 1H MR spectroscopy with respiratory navigator gating in volunteersRutger W van der Meer, Joost Doornbos, Sebastian Kozerke, et al.
Diabetes|August 10, 2010
Liver fat content in type 2 diabetes: relationship with hepatic perfusion and substrate metabolismLuuk J Rijzewijk, Rutger W van der Meer, Mark Lubberink, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|March 29, 2008
Stroke volume measurements with first-pass dynamic positron emission tomography: comparison with cardiovascular magnetic resonancePaul Knaapen, Mark Lubberink, Luuk J Rijzewijk, et al.
Diabetes Care|February 13, 2010
Pioglitazone decreases plasma cholesteryl ester transfer protein mass, associated with a decrease in hepatic triglyceride content, in patients with type 2 diabetesJacqueline T Jonker, Yanan Wang, Willeke de Haan, et al.
Pageof 2